Adagene, Inc. (ADAG)
2.68
+0.10
(+3.88%)
USD |
NASDAQ |
Oct 28, 10:17
Adagene Price : 2.68 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 2.48 | 2.67 | 2.44 | 2.58 | 189231.0 |
| Oct 26, 2026 | 2.42 | 2.55 | 2.34 | 2.49 | 91198.00 |
| Oct 23, 2026 | 2.43 | 2.57 | 2.295 | 2.41 | 167166.0 |
| Oct 22, 2026 | 2.24 | 2.51 | 2.24 | 2.44 | 244220.0 |
| Oct 21, 2026 | 2.55 | 2.55 | 2.39 | 2.41 | 96527.00 |
| Oct 20, 2026 | 2.30 | 2.50 | 2.30 | 2.50 | 92713.00 |
| Oct 19, 2026 | 2.04 | 2.29 | 2.01 | 2.29 | 308801.0 |
| Oct 16, 2026 | 2.40 | 2.40 | 2.01 | 2.06 | 379602.0 |
| Oct 15, 2026 | 2.31 | 2.42 | 2.26 | 2.40 | 552484.0 |
| Oct 14, 2026 | 2.35 | 2.50 | 2.25 | 2.29 | 898863.0 |
| Oct 13, 2026 | 2.73 | 2.73 | 2.435 | 2.46 | 228888.0 |
| Oct 12, 2026 | 2.77 | 2.855 | 2.68 | 2.74 | 216498.0 |
| Oct 09, 2026 | 2.76 | 2.87 | 2.625 | 2.76 | 1.649M |
| Oct 08, 2026 | 2.80 | 3.10 | 2.71 | 2.78 | 240466.0 |
| Oct 07, 2026 | 2.90 | 3.102 | 2.785 | 2.81 | 173066.0 |
| Oct 06, 2026 | 2.82 | 3.02 | 2.82 | 2.93 | 213515.0 |
| Oct 05, 2026 | 2.84 | 2.87 | 2.67 | 2.80 | 325707.0 |
| Oct 02, 2026 | 2.96 | 3.00 | 2.80 | 2.85 | 297967.0 |
| Oct 01, 2026 | 3.12 | 3.12 | 2.915 | 2.93 | 278281.0 |
| Sep 30, 2026 | 3.18 | 3.35 | 3.00 | 3.20 | 254322.0 |
| Sep 29, 2026 | 3.20 | 3.47 | 2.98 | 3.21 | 492589.0 |
| Sep 28, 2026 | 2.94 | 3.21 | 2.87 | 3.20 | 529852.0 |
| Sep 25, 2026 | 2.96 | 3.185 | 2.87 | 2.93 | 197662.0 |
| Sep 24, 2026 | 2.94 | 3.01 | 2.81 | 2.98 | 317092.0 |
| Sep 23, 2026 | 3.16 | 3.22 | 2.92 | 2.97 | 208023.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 0.72 |
| CStone Pharmaceuticals Co. Ltd. | 0.7547 |
| RemeGen Co., Ltd. | 9.96 |
| InnoCare Pharma Ltd. | 1.60 |
| JW (Cayman) Therapeutics Co. Ltd. | 0.2022 |
Price Related Metrics
| PS Ratio | 14.96 |
| Earnings Yield | -14.08% |
| Market Cap | 179.94M |